Literature DB >> 17402611

Aflatoxicosis in nine dogs after exposure to contaminated commercial dog food.

Shelley Joy Newman1, Joanne R Smith, Kate A Stenske, Leslie B Newman, John R Dunlap, Paula M Imerman, Claudia A Kirk.   

Abstract

The purpose of this study was to characterize light and electron microscopic findings from 9 dogs that had consumed aflatoxin-contaminated commercial dog food from recalled batches. Four dogs died and 5 were euthanized after signs of liver failure. Analysis of feed and liver samples confirmed exposure to aflatoxin. Of the 9 dogs, 8 had classic signs of liver failure, and 1 had signs of liver failure. Enlarged, pale yellow livers were seen macroscopically at necropsy in the dogs with subacute hepatopathy, and cirrhosis was noted in the dog with chronic hepatopathy. Histopathologic findings included hepatic lipidosis, portal fibroplasia, and biliary hyperplasia, which supported a diagnosis of subacute toxic hepatopathy in the 8 symptomatic animals. Marked lobular atrophy, bridging portal fibrosis, and regenerative hepatocellular nodules characterized the dog with chronic hepatopathy. Electron microscopy revealed marked hepatocellular lipid vacuolation and early fibroplasia in the dogs with acute hepatopathy and marked fibrosis and regeneration in the dog with chronic hepatopathy. Analysis of feed for aflatoxin consistently revealed high levels of aflatoxin B1 (range of 223-579 ppb), and hepatic tissue contained elevated levels of aflatoxin B1 metabolite M1 (0.6-4.4 ppb). Although dogs are not commonly affected by aflatoxicosis, they are highly susceptible and can present with classic signs of acute or chronic hepatopathy. Characteristic gross, histologic, and electron microscopic changes help pathologists determine a presumptive toxic insult. Detecting aflatoxins or their metabolites in feed or liver specimens can help confirm the diagnosis of aflatoxicosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17402611     DOI: 10.1177/104063870701900205

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

Review 1.  A review of class I and class II pet food recalls involving chemical contaminants from 1996 to 2008.

Authors:  Wilson Rumbeiha; Jamie Morrison
Journal:  J Med Toxicol       Date:  2011-03

2.  Thanatin confers partial resistance against aflatoxigenic fungi in maize (Zea mays).

Authors:  Max Schubert; Marcel Houdelet; Karl-Heinz Kogel; Rainer Fischer; Stefan Schillberg; Greta Nölke
Journal:  Transgenic Res       Date:  2015-06-13       Impact factor: 2.788

3.  Essential APSES Transcription Factors for Mycotoxin Synthesis, Fungal Development, and Pathogenicity in Aspergillus flavus.

Authors:  Guangshan Yao; Feng Zhang; Xinyi Nie; Xiuna Wang; Jun Yuan; Zhenhong Zhuang; Shihua Wang
Journal:  Front Microbiol       Date:  2017-11-20       Impact factor: 5.640

4.  A comparative analysis of mycotoxin contamination of supermarket and premium brand pelleted dog food in Durban, South Africa.

Authors:  Sanil D Singh; Anil A Chuturgoon
Journal:  J S Afr Vet Assoc       Date:  2017-10-06       Impact factor: 1.474

5.  ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs.

Authors:  Cynthia R L Webster; Sharon A Center; John M Cullen; Dominique G Penninck; Keith P Richter; David C Twedt; Penny J Watson
Journal:  J Vet Intern Med       Date:  2019-03-07       Impact factor: 3.333

Review 6.  Toxic Effect of Aflatoxins in Dogs Fed Contaminated Commercial Dry Feed: A Review.

Authors:  Lizbeth Martínez-Martínez; Arturo G Valdivia-Flores; Alma Lilian Guerrero-Barrera; Teódulo Quezada-Tristán; Erika Janet Rangel-Muñoz; Raúl Ortiz-Martínez
Journal:  Toxins (Basel)       Date:  2021-01-15       Impact factor: 4.546

7.  Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.

Authors:  John P Loftus; Adam J Miller; Sharon A Center; Jeanine Peters-Kennedy; Michael Astor
Journal:  J Vet Intern Med       Date:  2021-11-25       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.